Geographic · Total Revenue

Europe, the Middle East and Africa — Total Revenue

Idexx Laboratories Europe, the Middle East and Africa — Total Revenue increased by 1.1% to $257.05M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.7%, from $204.55M to $257.05M. Over 4 years (FY 2021 to FY 2025), Europe, the Middle East and Africa — Total Revenue shows an upward trend with a 8.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase suggests successful market expansion, higher adoption of diagnostic equipment, or increased utilization of reference lab services in the region, while a decrease may indicate competitive pressure, economic headwinds, or reduced veterinary clinic activity.

Detailed definition

This metric represents the total consolidated revenue generated from the sale of diagnostic products, equipment, and vet...

Peer comparison

Comparable to regional revenue reporting for other multinational healthcare or medical device companies, often benchmarked against regional GDP growth and veterinary market spending trends.

Metric ID: idxx_segment_europe_the_middle_east_and_africa_total_revenue

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$171.55M$167.96M$171.19M$173.81M$161.99M$152.24M$159.00M$176.01M$178.67M$177.85M$183.66M$199.83M$200.69M$198.61M$207.61M$204.55M$233.27M$245.06M$254.37M$257.05M
QoQ Change-2.1%+1.9%+1.5%-6.8%-6.0%+4.4%+10.7%+1.5%-0.5%+3.3%+8.8%+0.4%-1.0%+4.5%-1.5%+14.0%+5.1%+3.8%+1.1%
YoY Change-5.6%-9.4%-7.1%+1.3%+10.3%+16.8%+15.5%+13.5%+12.3%+11.7%+13.0%+2.4%+16.2%+23.4%+22.5%+25.7%
Range$152.24M$257.05M
CAGR+8.9%
Avg YoY Growth+10.2%
Median YoY Growth+12.7%
Current Streak4 quarters growth

Frequently Asked Questions

What is Idexx Laboratories's europe, the middle east and africa — total revenue?
Idexx Laboratories (IDXX) reported europe, the middle east and africa — total revenue of $257.05M in Q1 2026.
How has Idexx Laboratories's europe, the middle east and africa — total revenue changed year-over-year?
Idexx Laboratories's europe, the middle east and africa — total revenue increased by 25.7% year-over-year, from $204.55M to $257.05M.
What is the long-term trend for Idexx Laboratories's europe, the middle east and africa — total revenue?
Over 4 years (2021 to 2025), Idexx Laboratories's europe, the middle east and africa — total revenue has grown at a 8.3% compound annual growth rate (CAGR), from $681.95M to $937.25M.
What does europe, the middle east and africa — total revenue mean?
The total amount of money earned from sales and services provided to customers located in the Europe, Middle East, and Africa region.